logo


Rigel Pharmaceuticals Prices Public Offer at $7.25
Friday, September 18, 2009 9:52 AM


(Source: Datamonitor)trackingRigel Pharmaceuticals, a US-based drug development company, has priced an underwritten public offering of 13 million of its common stock at $7.25 per share. All of the shares are being offered by Rigel.

The underwriters have an option to purchase up to an additional 1.95 million shares to cover over-allotments, if any. The offering is expected to close on September 22, 2009, subject to the satisfaction of customary closing conditions.

Credit Suisse Securities (USA) is acting as the sole book-runner for the offering, with Oppenheimer & Co and Thomas Weisel Partners acting as co-managers.

A service of YellowBrix, Inc.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia